Prostate Cancer
The use of focal therapy for the treatment of prostate cancer in Canada: Where are we, how did we get here, and where are we going?
October 25, 2024
Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards.
October 24, 2024
Should Military Veterans Be Classified as High Risk for Prostate Cancer Screening? A Systematic Review and Meta-analysis.
October 24, 2024
Acute pancreatitis and biliary obstruction from metastatic lymph node compression during [177Lu] Lu-PSMA-617 therapy: a case report.
October 23, 2024
Protein kinase D1 mitigation against etoposide induced DNA damage in prostate cancer is associated with increased α-Catenin.
October 23, 2024
Ferroptosis-related gene signature predicts prognosis and immune microenvironment in prostate cancer.
October 23, 2024
Castration Levels of Testosterone Results in Atrophy of Androgen-Sensitive Perineal Muscles: A Potential Biomarker for Male Hypogonadism.
October 22, 2024
Comparative efficacy and safety of talazoparib plus enzalutamide and other first-line treatments for metastatic castration-resistant prostate cancer.
October 22, 2024
Multivariable models of outcomes with [177Lu]Lu-PSMA-617: analysis of the phase 3 VISION trial.
October 22, 2024